Skip to main content
HOPA Abstracts
Use of Ursodiol for SOS/VOD Prophylaxis in Patients with Acute Leukemia Receiving Gemtuzumab-Ozogamicin or Inotuzumab-Ozogamicin
Abstract #CR20
Read More
HOPA Abstracts
Use of Bevacizumab Originator versus Biosimilar Drugs for Oncology Indications in a Real-World Data Sample
Abstract #CR21
Read More
HOPA Abstracts, Tyrosine Kinase Inhibitor
Veterans Health Administration Pharmacy Benefits Management Anti-Cancer Stewardship Pilot: Why Switch to a Second-Line Tyrosine Kinase Inhibitor for the Treatment of Chronic Myeloid Leukemia?
Abstract #CR22
Read More
HOPA Abstracts
Assessment and Education of Biosimilars Across an Outpatient Oncology Infusion Network
Abstract #CR23
Read More
HOPA Abstracts
Optimizing Corticosteroid Use for Immune-Related Adverse Events at a Community Oncology Practice
Abstract #LB01
Read More
HOPA Abstracts
Efficacy of Tixagevimab-Cilgavimab in Preventing SARS-CoV-2 in Patients with Hematologic Malignancies
Abstract #LB02
Read More
HOPA Abstracts
Potentially Inappropriate Medication Use and Cognition in Older Women with Breast Cancer
Abstract #LB03
Read More
HOPA Abstracts
Safety and Tolerability of an Alternative Capecitabine Dosing Schedule in Patients with Colorectal Cancer
Abstract #LB04
Read More
Editorial
Keeping the HOP(A) Live—Annual Conference Research Highlights
By Mark L. Zangardi, PharmD, MS, BCOP; Sara Kim, PharmD, BCOP
Read More
HOPA Abstracts
Biosimilar Uptake and Cost-Savings Analysis Before and After the Implementation of a Pharmacist-Driven Substitution Program Within a National Community Oncology Network
Abstract #CR02
Read More
Page 36 of 196
Results 351 - 360 of 1953